Approval · Notice of Compliance 10198 · 2009
PMS-TESTOSTERONE: Notice of Compliance 10198
Issued May 8, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10198
- Date
- May 8, 2009
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Androgen
- Canadian reference product
- ANDRIOL (Organon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-TESTOSTERONE | 02322498 | Dormant |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 40 MG per CAP